Twelve month oral contraceptive pill prescriptions: Role of policy mandates on utilization

Peasah, SamuelK.; Kohli, Monal; Munshi, Kiraat D.; Henderson, Rochelle; Mueller, Mark W.; Manolis, Chronis; Huang, Yan; Swart, Elizabeth C S; Neilson, Lynn M.; Good, Chester B.

doi:10.1016/j.rcsop.2021.100094

Cited by 2 publications

(4 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our study demonstrated suboptimal awareness of this law among clinicians participating in the study. This experience is similar to other states 24,25 . For example, Oregon passed a similar 12‐month supply provision into law in January 2016 and disseminated information about this policy change to its network of publicly funded contraceptive clinics 26 .…”

Section: Discussionsupporting

confidence: 60%

“…This experience is similar to other states. 24,25 For example, Oregon passed a similar 12-month supply provision into law in January 2016 and disseminated information about this policy change to its network of publicly funded contraceptive clinics. 26 Only 3.7% of SARC users in Oregon received a 12-month supply after the policy change (compared to 3.5% prior to policy).…”

Section: Variation In Clinicians' Perceptions Regarding the Lawmentioning

confidence: 99%

See 1 more Smart Citation

A qualitative study of clinicians' perspectives on a law that allows for a 12‐month supply of short‐acting contraceptives in Massachusetts: Barriers and facilitators to implementation

Qasba

Dowd

Bianchet

et al. 2022

Health Services Research

View full text Add to dashboard Cite

Objective: To explore clinicians' perspectives regarding the Massachusetts 2017 law, 'An Act Relative to Advancing Contraceptive Coverage and Economic Security in Our State' (ACCESS), including awareness of the law, perceived barriers and facilitators to successful implementation, and recommendations to improve uptake. ACCESS requires all insurers, except self-insured businesses, to cover short-acting reversible contraceptives (SARCs) at no cost to patients and for a 12-month supply to be prescribed/dispensed if desired after the completion of a three-month trial.

show abstract

Section: Discussionsupporting

confidence: 60%

Section: Variation In Clinicians' Perceptions Regarding the Lawmentioning

confidence: 99%

A qualitative study of clinicians' perspectives on a law that allows for a 12‐month supply of short‐acting contraceptives in Massachusetts: Barriers and facilitators to implementation

Qasba

Dowd

Bianchet

et al. 2022

Health Services Research

View full text Add to dashboard Cite

show abstract

“…23 The decrease in prevalence of oral contraceptives at the 4 and 6-month assessment windows compared with the 2-month window may be due to multi-month packs resulting in less frequent refills. 24 Oral norethindrone, the most commonly dispensed medication in this study, is the oral hormonal contraceptive recommended for lactating people 25 because it does not contain estradiol, which can suppress lactation and increase the risk of thromboembolism, especially after delivery. 26 Combination oral contraceptives (e.g., desogestrel and ethinyl estradiol) are not recommended during the first 6 weeks' postpartum.…”

Section: Discussionmentioning

confidence: 98%

“…Additionally, lower prevalence estimates at later timepoints may be expected as patients discontinue medications for pregnancy, delivery, and early postpartum‐related indications, for example, labetalol and nifedipine prescribed for hypertensive disorders of pregnancy; NSAIDs and opioids prescribed for pain relief following delivery; cephalexin and dicloxacillin prescribed for lactational mastitis, which is most common during the first few months postpartum 23 . The decrease in prevalence of oral contraceptives at the 4 and 6‐month assessment windows compared with the 2‐month window may be due to multi‐month packs resulting in less frequent refills 24 …”

Section: Discussionmentioning

confidence: 99%

The most common medications dispensed to lactating persons: An electronic health record‐based approach

Palmsten

Vazquez‐Benitez

Bandoli

et al. 2023

Pharmacoepidemiology and Drug

View full text Add to dashboard Cite

PurposeUsing a novel, electronic health record (EHR)‐based approach, to estimate the prevalence of prescription medication use at 2, 4, and 6 months postpartum among lactating individuals.MethodsWe utilized automated EHR data from a US health system that records infant feeding information at well‐child visits. We linked mothers who received prenatal care to their infants born May 2018–June 2019, and we required infants to have ≥1 well‐child visit between 31 and 90 days of life (i.e., 2‐month well‐child visit with a ±1 month window). Mothers were classified as lactating at the 2‐month well‐child visit if their infant received breast milk at the 2‐month well‐child visit. For subsequent well‐child visits at 4 and 6 months, mothers were considered lactating if their infant was still receiving breast milk.ResultsWe identified 6013 mothers meeting inclusion criteria, and 4158 (69.2%) were classified as lactating at the 2‐month well‐child visit. Among those classified as lactating, the most common medication classes dispensed around the 2‐month well‐child visit were oral progestin contraceptives (19.1%), selective serotonin reuptake inhibitors (8.8%), first generation cephalosporins (4.3%), thyroid hormones (3.5%), nonsteroidal anti‐inflammatory agents (3.4%), penicillinase‐resistant penicillins (3.1%), topical corticosteroids (2.9%), and oral imidazole‐related antifungals (2.0%). The most common medication classes were similar around the 4 and 6‐month well‐child visits although prevalence estimates were often lower.ConclusionsProgestin‐only contraceptives, antidepressants, and antibiotics were the most dispensed medications among lactating mothers. With routine collection of breastfeeding information, mother‐infant linked EHR data may overcome limitations in previous studies of medication utilization during lactation. These data should be considered for studies of medication safety during lactation given the need for human safety data.

show abstract

Twelve month oral contraceptive pill prescriptions: Role of policy mandates on utilization

Cited by 2 publications

References 14 publications

A qualitative study of clinicians' perspectives on a law that allows for a 12‐month supply of short‐acting contraceptives in Massachusetts: Barriers and facilitators to implementation

A qualitative study of clinicians' perspectives on a law that allows for a 12‐month supply of short‐acting contraceptives in Massachusetts: Barriers and facilitators to implementation

The most common medications dispensed to lactating persons: An electronic health record‐based approach

Contact Info

Product

Resources

About